Famotidine Powder, For Suspension
Product Images NDC 80005-119

2 FDA label images from Carnegie Pharmaceuticals Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Famotidine (NDC 80005-119). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Carnegie Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemstructure (Chemstructure)

Chemstructure (Chemstructure)
Chemical structure diagram of famotidine, showing the arrangement of its molecular components including sulfur, nitrogen, and oxygen atoms within the molecule.*
FDA Label Image

Containerlabel (Image01)

Containerlabel (Image01)
Label for Famotidine for Oral Suspension USP 40 mg/5 mL powder for suspension, oral use. Contains 400 mg of famotidine per 50 mL reconstituted suspension. Instructions include directions for reconstitution, storage, and suspension use. Manufactured by Carnegie Pharmaceuticals LLC, Delran, NJ. The label includes a barcode and a note to shake well before use.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.